Literature DB >> 10326727

Sequence variations of the CST2 gene related to the polymorphism of salivary cystatin SA.

T Haga1, K Minaguchi.   

Abstract

The CST2 locus has two polymorphic alleles, CST2*1 and CST2*2, which produce cystatin proteins SAI and SA2, respectively (Shintani et al., 1994). The purpose of this study was to define nucleotide sequence variations of the protein-coding region of the two alleles. The variations were investigated by direct sequencing of amplified DNA from individuals with different CST2 phenotypes. The sequence of three exons obtained from DNA of the CST2 1 phenotype was found to be identical to the published sequence of the CST2 gene (Saitoh et al., 1987), whereas two-point mutations were found in the sequence obtained from DNA of the CST2 2 phenotype. One of the mutations was a G --> A transition in exon 2, resulting in loss of a commonly occurring AciI restriction site. This mutation resulted in a Gly59 --> Asp59 substitution in the protein. The other mutation was an A --> T transversion in exon 3, resulting in the generation of a SfaNI restriction site. This mutation also produced a Glu120 --> Asp120 substitution in the protein. PCR-RFLP assay with AciI and SfaNI restriction enzymes revealed that the two-point mutations were always correlated with cystatin SA polymorphism. The difference in the electrophoretic positions of the two proteins, SA1 and SA2, in a basic gel and in an isoelectric focusing gel agreed with the expected mobilities of the proteins with the SA2 variant at a more anodal position. The CST2*2 allele is a unique allele, which shows amino acid substitution in one of the most conserved regions responsible for cysteine proteinase inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10326727     DOI: 10.1177/00220345990780040301

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  3 in total

1.  Identification and validation of a prognostic 9-genes expression signature for gastric cancer.

Authors:  Zhiqiang Wang; Gongxing Chen; Qilong Wang; Wei Lu; Meidong Xu
Journal:  Oncotarget       Date:  2017-05-10

2.  Murine monoclonal antibody which can distinguish cystatins SA1 and SA2.

Authors:  Taichi Ito; Akiyo Komiya-Ito; Katsuji Okuda; Kiyoshi Minaguchi; Eiichi Saitoh; Satoru Yamada; Tetsuo Kato
Journal:  Mol Immunol       Date:  2005-01-08       Impact factor: 4.407

3.  Identification of Cysteine Protease Inhibitor CST2 as a Potential Biomarker for Colorectal Cancer.

Authors:  Qiurong Xie; Liya Liu; Xiaoping Chen; Ying Cheng; Jiapeng Li; Xiuli Zhang; Nanhui Xu; Yuying Han; Huixin Liu; Lihui Wei; Jun Peng; Aling Shen
Journal:  J Cancer       Date:  2021-06-22       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.